Prävention kardiovaskulärer Erkrankungen und Atherosklerose

Nach Angaben der Weltgesundheitsorganisation (World Health Organization, WHO) sind Krankheiten des Herz-Kreislauf-Systems weltweit fur etwa ein Drittel aller Todesfalle verantwortlich und stellen somit die haufigste Todesursache dar (World Health Organization 2002). In Deutschland wurden fur das Jahr 2006 insgesamt ca. 360.000 Todesfalle durch Krankheiten des Kreislaufsystems verzeichnet (WHO 2004), was einem Anteil von etwa 45 % an der Gesamtmortalitat entspricht.

[1]  C. Kunsch,et al.  Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. , 2004, American journal of physiology. Heart and circulatory physiology.

[2]  Claudio Borghi,et al.  Integrated management of cardiovascular risk , 2008 .

[3]  M. Cybulsky,et al.  NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .

[4]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[5]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[6]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[7]  J. Joven,et al.  Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. , 2003, Clinical chemistry.

[8]  P. Davies,et al.  Spatial hemodynamics, the endothelium, and focal atherogenesis: a cell cycle link? , 2000, Circulation research.

[9]  P. Libby.  Managing the risk of atherosclerosis: the role of high-density lipoprotein. , 2001, The American journal of cardiology.

[10]  P. Ridker,et al.  C-reactive protein and other inflammatory risk markers in acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[11]  S. Pan,et al.  Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress. , 2009, Antioxidants & redox signaling.

[12]  O. Wagner,et al.  Prognostic Impact of Fibrinogen in Carotid Atherosclerosis: Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression? , 2005, Stroke.

[13]  P. Shaul.  Regulation of endothelial nitric oxide synthase: location, location, location. , 2002, Annual review of physiology.

[14]  A. Name.  Gesundheitsberichterstattung des Bundes , 2010 .

[15]  M. Aviram,et al.  Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. , 2004, Free radical biology & medicine.

[16]  Gerald Rimbach,et al.  Impact of apoE genotype on oxidative stress, inflammation and disease risk. , 2008, Molecular nutrition & food research.

[17]  C. Ballantyne,et al.  Cardiology patient page. Measurement of cholesterol: a patient perspective. , 2004, Circulation.

[18]  L. Liu,et al.  Nitric Oxide: from a mysterious labile factor to the molecule of the Nobel PrizeRecent progress in nitric oxide research , 1998, Cell Research.

[19]  R. Dean,et al.  Atherosclerosis Gene Expression Cell Interactions and Oxidation , 2000 .

[20]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[21]  F. Hofmann,et al.  Function of cGMP-dependent protein kinases as revealed by gene deletion. , 2006, Physiological reviews.

[22]  J P Ornato,et al.  Cardiology patient page: warning signs of a heart attack. , 2001, Circulation.

[23]  R. Ginnan,et al.  Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. , 2008, Free radical biology & medicine.

[24]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  H. Soran,et al.  Variation in paraoxonase-1 activity and atherosclerosis , 2009, Current opinion in lipidology.